Günther Enderlein

Günther Enderlein (born 7 July 1872 in Leipzig; died 11 August 1968 in Wentdorf near Hamburg) was a German zoologist, entomologist and later a manufacturer of pharmaceutical products near Hamburg. Enderlein got some international fame because of his research about insects, but in Germany he became famous because of his concept of pleomorphism of microorganisms and his hypotheses about the origins of cancer, based on former work of other scientists. His hypotheses about pleomorphism and cancer have been disproved in the meantime by science and have only some historical importance today. Some of his concepts are however still popular in complementary medicine. A controversial blood test is named after Enderlein: "dark field microscopy according to Enderlein".

Life

Enderlein was born in Leipzig as the son of a teacher, he studied in Leipzig and Berlin und got his PhD in 1898 as a zoologist. He became professor in 1924. First he worked as assistant at the zoological museum in Berlin, and went later to Szczecin (Poland, at that time Germany). During the first world war he worked as military surgeon major (despite he was a biologist), as there where not enough physicians available at that time. He returned to Berlin in 1919 and remained there until 1937. After 1933 he became production manager in a small pharmaceutical company: Sanum (that later became Sanum-Kehlbeck). In 1944 he founded his own pharmaceutical company IBICA in Berlin, transferred later to Hamburg. He was also publisher of a newspaper called Akmon. After his death, IBICA and Sanum merged in 1975 to form the Sanum-Kehlbeck company still active today.

cientific work and his theories about pleomorphism and origins of diseases

Enderlein published more than 500 scientific articles, mostly about insects. He worked in taxonomy and systematics of many Diptera families (insects). Many insects were named by him and some carry his name. His way of distinction by external characteristics led to some disputes inside the scientific community of that time (see Zwick 1995 for details). Enderlein was mostly interested in Simuliidae (a Diptera family).

In 1916 he published an article about spotted fever.

He caused more sensation, however, when he developed and published his concepts about a pleomorphism of microorganisms. Concept of pleomorphism was quite controversial at the end of the 19th century and the beginning 20th century. At the end the monomorphism concept of Louis Pasteur took overhand.

The term pleomorphism comes from Greek pleion = more, morphe = figure, and was apparently created by French chemist and biologist Pierre Jacques Antoine Béchamp (1816-1908). Similar concepts are known in ancient times as concepts of a abiogenesis, but disproved during 18th century.

Based on early work of Bechamp, who was an opponent of Louis Pasteur, and based on a point of view of contemporary Wilhelm von Brehmer (1883-1958), and based on his own microscopic observation, he developed his own complicated pleomorphism hypothesis. He was convinced that every microorganism would pass through a particular development-cycle, that he called cyclode (bacterial cyclode). Bechamp had issued earlier the opinion that in every animal or plant cell there were small particles, that he called microzymas or granulations moleculaires. These particles were able to transform into pathogen bacteries, under certain circumstances. Pasteur and the scientific community did not accept this opinion.

At that time it was also known that plasmodia (causing agents of malaria) were able to change form during the different development stages.

In 1925 Enderlein published his main work: Bakterien-Cyklogenie. He developed not only a complex hypothesis, but at the same time he created also his own terminology that makes reading of his papers difficult or even impossible. He stated that small harmless and benificious herbal particles were present in every animal or plant and may transform into larger and pathogen bacteries or fungi under certain circumstances. The smallest particles are called protit, symbionts or endobionts. Protits are, according to Enderlein, small colloids of proteins, sized between 1 and 10 nm. Enderlein made a difference between acid and alcalic symbionts. These particles are able to be transmitted via the placenta before the birth.

Enderlein was convinced that these small particles were harmless and necessary for health. Only the larger organisms developed out of these particles were pathogen bacteria or fungi, Enderlein uses the word valent for pathogen. The smaller harmless particles are able to interact and to control the larger valent particles or organisms by their ability to destroy them by a process of merging. After death the smallest particles survive and may serve for another host-organism, and they participate in the process of decomposition.

A disturbance of the symbiotic friendly coexistence between the smaller particles and the larger organism would start a dangerous situation he called mochlosis that leads at the end to a disease, facilitated by a wrong way of thinking and living. In such a case, he speaks about an increase of valenz, the most primitive protits would build up one-dimensional chains, called filit. These filits may build up a two dimensional and later three dimensional net of Filits. But this only in the case of presence of a pH higher than 7,3. I a healthy ambience such a filit-net may never build up. The filit-net leads to larger particle: the symprotits and later the chondrits. These chondrits have more or less the size of a virus with 15-300 nm in size. The dark field microscopy is able to show them, says Enderlein. If this process continues, we will observe larger particles called mychits, or bacteria-nuclei forming the basis of a bacterium.

• apathogenic forms within a cyclode are: protit, filium, filit, spermit, symprotit, chondrit, microchondrit• pathogenic forms (dynamovalent) are: makrosymprotit, makrochondrit, sporoid symprotit, filitnet, mychit (bacterial nucleus), cystit, thecit, diökothecit, bacteria, streptococcus, staphylococus, Mycobacterium tuberculosis, amoebit, zoit.

(other named stages are: Basit, Phytit, Rhabdit, Cystit, Linit, Ascit, Synascit )

According to Enderlein, the different diseases of man are related to particular cyclodes leading to particular microorganisms. He was mainly interested in two cyclodes: the cyclode leading to fungus mucor racemosus and the cyclode leading to fungus aspergillus niger. The mucor racemosus cyclode leads to diseases concerning the blood, spine and rheumatism. In these cases a marcant filit-net should always be present. An injection of harmless symbionts may help here, as they are able to destroy larger valent microorganisms.

The aspergillus niger cyclode leads to diseases of lung, tuberculosis and cancer. In this case, an injection of symbionts may be helpful.

Enderlein was convinced that bacteria may increase in number or by an asexual division or by another sexual way of merging the two nuclei before division.

Developed bacteria and fungi may regress or downgrade back to harmless particles, but this process is only possible in a healthy host organism. But the use of some catalytic acting drugs may support that process: The chondritins.

Today the preparations developed by Professor Enderlein are manufactured and distributed worldwide by SANUM-Kehlbeck GmbH & Co. KG in Hoya, Germany. The protit and other non-pathogenic forms within a cyclode after Enderlein is not identical to the pathogenic prions discussed today. Clarification on this subject, based on scientific criteria, issued by the Institute for Virology of the Technical University Munich can be obtained free of charge at [e-mail].

References

*Bacteria cyclogeny: Prolegomena to a study of the structure, sexual and asexual reproduction and development of bacteria, Prof. Dr. Günther Enderlein, PleomorphicSANUM, 5170 W. Phelps Road, Glendale, AZ 85306, USA
*AKMON, Band I-III, Prof. Dr. Günther Enderlein, Semmelweis-Institut Verlag für experimentelle Onkologie GmbH, Germany
*Introduction into darkfield diagnostics, Franz Arnoul / Cornelia Schwerdtle Semmelweis-Institut Verlag für experimentelle Onkologie GmbH, Germany
*Unappreciated Friend or unsuspected Foe?, Dr. med M.-M. Bleker Semmelweis-Institut Verlag für experimentelle Onkologie GmbH, Germany

External links

*http://www.sanumaustralia.com